Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. - Wikidata - awgldk - TriplyDB

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

http://www.wikidata.org/entity/Q34608887

about

Therapeutic radionuclides in nuclear medicine: current and future prospects Theranostic Imaging of Yttrium-90 Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging.Diagnosis and treatment of carcinoid tumors.Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.Improved quality of life in patients treated with Peptide radionuclides.Progress in the treatment of neuroendocrine tumors.Gastric neuroendocrine tumours.Direct one-step labeling of cysteine residues on peptides with [(11)C]methyl triflate for the synthesis of PET radiopharmaceuticals.Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues Applications of molecular imaging.Peptide-targeted radionuclide therapy for melanoma.Targeted therapy in advanced well-differentiated neuroendocrine tumors.A new era for the systemic therapy of neuroendocrine tumors.Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Molecular probes for the in vivo imaging of cancer.Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts.Cancer treatment using peptides: current therapies and future prospects Emerging therapies for the treatment of patients with advanced neuroendocrine tumors.Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.From somatostatin to octreotide LAR: evolution of a somatostatin analogue Somatostatin stimulates menin gene expression by inhibiting protein kinase A.Three-dimensional imaging-based radiobiological dosimetry.Hyperpolarized (89)Y offers the potential of direct imaging of metal ions in biological systems by magnetic resonance.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.Peptide receptor therapies in neuroendocrine tumors.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Receptor-mediated tumor targeting based on peptide hormones.Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review.Yttrium-labelled peptides for therapy of NET.¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.Lutetium-labelled peptides for therapy of neuroendocrine tumours.Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumors.

P2860

Q26861998-F70B29BB-79A0-4DD2-AF7F-0ABC49E4079F Q28083044-4BADC100-C7A9-453A-BACB-F1D5626E117B Q30472127-68561720-620D-4192-9AC9-D14A008D1562 Q33196127-B188574A-8394-4362-8597-DC09B580D041 Q33247993-EC430B23-51AE-4579-A12A-8D5520A53705 Q33346935-3AD50B68-9E40-4FAD-A9B2-C855648980FB Q33392694-989477FE-CCE2-4FB1-914A-2C3F1077C61B Q33398609-B9A834D0-83D0-4C5F-8DBF-5C7573D4C3AF Q33643643-E6CDAB0D-131F-431D-9AC7-03A20BA6937A Q34306680-2C0FD04A-8731-4983-AA89-3B6E34C827DF Q34362306-3B0EBCA6-AB0C-4975-A7C9-97655D694882 Q34395062-DC7EDB0E-C150-4E02-A0E7-C7A3512CBE91 Q35082412-BC0AB077-8AA7-40A7-9A7D-89B4B74D5E08 Q35393994-58B19696-C5C1-4623-B1DF-642323F9D821 Q35584497-06A116B3-BCD1-4506-92A9-181DC2DF6ED5 Q35863865-990FCA8E-AB9F-4665-A5F0-FF928287D6BE Q35880923-FCA3A312-7DEA-45E5-895F-34B4AC31C724 Q35999552-8712445A-0E33-48E5-AD45-1120E508612E Q36008285-E498ACBF-7F99-4D10-B29B-54FE6AE182C7 Q36125208-C24DC63A-C734-4607-B556-B8B4530AC920 Q36377941-73A72966-8F39-42F5-A4D3-B970FA520706 Q36462856-2A38610F-1366-4AA4-B4A0-408BD98758B8 Q36515785-9DD37AF0-C580-4916-8D0B-722F67DCEE97 Q36866607-C0DB779D-281C-439B-8CE7-77547F3EC9A9 Q36892294-33D99441-E51F-4E73-BB76-528EE464C37E Q36919554-B5A149F2-AD54-4FED-82E0-6DCDC9F6C4D9 Q36956111-B60E714E-8AC0-4BC6-A439-53AEB2F06CAA Q37002485-67F04F9C-8562-4FB6-81C7-2EB64661A25A Q37003319-6024F119-4125-4F36-9508-18ABD90D28E8 Q37085052-F9168897-5A51-49D0-B25E-82FD93B724C5 Q37106150-0E565B06-64A0-4A0B-A796-B664A0DBAC5A Q37374442-7E80372F-1AA9-42DB-856A-80A5E0FFE581 Q37563878-67826B74-100A-4C82-84AF-739D494761A7 Q37564373-C7EF7335-9C8F-45C4-BB0F-69B926520DC8 Q37641368-3CD11C5B-2909-4552-ADD4-3C58383BAD78 Q37812297-460F3041-BD4E-4BCF-9457-18A00519BE4D Q37990401-E55191B3-8642-4CD1-A7DC-B240629751DC Q37990403-720505F9-CB36-419D-81D3-DCDC3EEF1529 Q37990411-7239715B-41B8-476D-BBCC-A176FC941FB1 Q38769465-E20BD30F-DABA-4E80-9535-E2B2C04CD8B1

P2860

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

http://www.wikidata.org/entity/Q34608887

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Somatostatin receptor-targeted ...... linical and clinical findings.

@ast

Somatostatin receptor-targeted ...... linical and clinical findings.

@en

Somatostatin receptor-targeted ...... linical and clinical findings.

@nl

type

label

Somatostatin receptor-targeted ...... linical and clinical findings.

@ast

Somatostatin receptor-targeted ...... linical and clinical findings.

@en

Somatostatin receptor-targeted ...... linical and clinical findings.

@nl

prefLabel

Somatostatin receptor-targeted ...... linical and clinical findings.

@ast

Somatostatin receptor-targeted ...... linical and clinical findings.

@en

Somatostatin receptor-targeted ...... linical and clinical findings.

@nl

P1433

Q34608887-40DA195D-DDF5-421C-98AA-CFE92B4BC229

P1476

Q34608887-4CC1BC60-5F58-45A6-BDBA-E486E10EDCDD

P2093

Q34608887-073F5A1B-EFAF-433D-8CC6-880D5FEEA510

Q34608887-265CE82C-EAFB-4EC7-A707-A76A114D57E9

Q34608887-36C2408F-078F-4F75-B02A-ADD7B9463DB0

Q34608887-386BAAC0-3ED9-4EC5-B14D-EB5689820426

Q34608887-5B388EAE-938E-4B2C-AD6E-C25D67BC3ED8

Q34608887-622D9E47-C2F9-4B3B-8DF3-F7CB05948A3F

Q34608887-6A31C4B7-A436-4785-A00C-C7BCD2CD9527

Q34608887-7F9B8AAB-DBD9-4F36-B76F-12623E0992C6

Q34608887-817CFA83-E04A-4BCC-BE19-30E75D845656

Q34608887-B58B5D2D-D36E-4ACF-A37E-3F92A8FE56A1

P304

Q34608887-8BABDB78-1A75-4302-AFB3-3ADFA1447EF1

P31

Q34608887-54476731-6C53-449F-BA30-2D7612BBA64F

P356

Q34608887-133BE938-9FBE-45B7-93F7-ADF1D49BD702

P433

Q34608887-094F3C9D-4AE4-4992-8918-43CB0BE53992

P478

Q34608887-347D667F-F2E3-4A44-9527-4C016F61C8A2

P577

Q34608887-DDBC04B5-0F4C-40FA-BE61-905AE9D4137B

P698

Q34608887-F94DDCEC-4093-4CEF-9E0A-2496110FFAC6

P356

SNUC.2002.31027

P1433

Seminars in Nuclear Medicine

P1476

Somatostatin receptor-targeted ...... linical and clinical findings.

@en

P2093

Chuck Smith

http://www.w3.org/2001/XMLSchema#string

Dik J Kwekkeboom

http://www.w3.org/2001/XMLSchema#string

Eric P Krenning

http://www.w3.org/2001/XMLSchema#string

Francois Jamar

http://www.w3.org/2001/XMLSchema#string

Larry K Kvols

http://www.w3.org/2001/XMLSchema#string

Marion De Jong

http://www.w3.org/2001/XMLSchema#string

Roelf Valkema

http://www.w3.org/2001/XMLSchema#string

Stanislas Pauwels

http://www.w3.org/2001/XMLSchema#string

Willem H Bakker

http://www.w3.org/2001/XMLSchema#string

Wout A P Breeman

http://www.w3.org/2001/XMLSchema#string

P304

133-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/SNUC.2002.31027

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11965608

http://www.w3.org/2001/XMLSchema#string